glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1R antibody [EPR21819]. Rabbit Monoclonal
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1R antibody [EPR21819]. Rabbit Monoclonal](https://content.abcam.com/products/images/glp-1r-antibody-epr21819-ab218532--immunohistochemistry-frozen-sections-img34413.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1R antibody [EPR21819]. Rabbit Monoclonal](https://content.abcam.com/products/images/glp-1-antibody-24h1l3-ab200474--western-blot-img44844.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Cited in 1 publication Anti-GLP-1R antibody [EPR21819]. Rabbit Monoclonal](https://www.thermofisher.com/antibody/images/150/710320_WB.jpg?time=20220826)









/assets/images/provider/photos/2793649.jpeg)










